These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 11984616

  • 1. Rubella immunization strategies in the state of São Paulo, Brazil.
    Rymkiewicz E, Zuzarte FC, de Oliveira Campos S, Pinto MI.
    Bull World Health Organ; 2002; 80(3):258. PubMed ID: 11984616
    [No Abstract] [Full Text] [Related]

  • 2. MMR vaccination: new thought.
    Deshmukh V.
    Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
    [No Abstract] [Full Text] [Related]

  • 3. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A, Torner N, Martínez A, Costa J, Plans P, Ciruela P, Salleras L.
    Vaccine; 2006 Feb 27; 24(9):1433-7. PubMed ID: 16226357
    [Abstract] [Full Text] [Related]

  • 4. Accelerated rubella and congenital rubella syndrome programme, Costa Rica.
    Wkly Epidemiol Rec; 2001 Aug 31; 76(35):265-70. PubMed ID: 11565150
    [No Abstract] [Full Text] [Related]

  • 5. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F, Reef S, Massoudi M, Papania MJ, Yusuf HR, Bardenheier B, Zimmerman L, McCauley MM.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [Abstract] [Full Text] [Related]

  • 6. Accelerated rubella control and congenital rubella syndrome prevention strengthen measles eradication: the Costa Rican experience.
    Morice A, Carvajal X, León M, Machado V, Badilla X, Reef S, Lievano F, Depetris A, Castillo-Solórzano C.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S158-63. PubMed ID: 12721908
    [Abstract] [Full Text] [Related]

  • 7. Progress toward implementation of a second-dose measles immunization requirement for all schoolchildren in the United States.
    Kolasa MS, Klemperer-Johnson S, Papania MJ.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S98-103. PubMed ID: 15106097
    [Abstract] [Full Text] [Related]

  • 8. Measles and rubella in the World Health Organization European region: diversity creates challenges.
    Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, Emiroglu N.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S191-7. PubMed ID: 12721913
    [Abstract] [Full Text] [Related]

  • 9. [The risks of a mismanaged immunization program: the example of vaccination against rubella].
    Lévy-Bruhl D.
    Rev Epidemiol Sante Publique; 2000 Jun 15; 48(3):309-10. PubMed ID: 10991720
    [No Abstract] [Full Text] [Related]

  • 10. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
    Tseng HF, Chang CK, Tan HF, Yang SE, Chang HW.
    Vaccine; 2006 Jul 17; 24(29-30):5772-7. PubMed ID: 16759764
    [Abstract] [Full Text] [Related]

  • 11. [Rubella in Poland in 2005].
    Czarkowski MP, Stefanoff P.
    Przegl Epidemiol; 2007 Jul 17; 61(2):199-206. PubMed ID: 17956032
    [Abstract] [Full Text] [Related]

  • 12. The evidence for the elimination of rubella and congenital rubella syndrome in the United States: a public health achievement.
    Reef SE, Cochi SL.
    Clin Infect Dis; 2006 Nov 01; 43 Suppl 3():S123-5. PubMed ID: 16998770
    [No Abstract] [Full Text] [Related]

  • 13. [Rubella in Poland in 2007].
    Rogalska J, Rzepczak E, Stefanoff P.
    Przegl Epidemiol; 2009 Nov 01; 63(2):177-80. PubMed ID: 19799240
    [Abstract] [Full Text] [Related]

  • 14. Measles immunization in Saudi Arabia: the need for change.
    Khalil MK, Al-Mazrou YY, Al-Jeffri M, Al-Ghamdy YS.
    East Mediterr Health J; 2001 Nov 01; 7(4-5):829-34. PubMed ID: 15332786
    [Abstract] [Full Text] [Related]

  • 15. [Rubella].
    Zappe HA, Hassler D.
    Dtsch Med Wochenschr; 2002 Sep 27; 127(39):1992. PubMed ID: 12391974
    [No Abstract] [Full Text] [Related]

  • 16. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 27; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 17. Emerging issues in immunization.
    Havaldar PV.
    Indian Pediatr; 2002 Jan 27; 39(1):106-7; author reply 108-11. PubMed ID: 11805368
    [No Abstract] [Full Text] [Related]

  • 18. Measles in Mexico, 1941-2001: interruption of endemic transmission and lessons learned.
    Santos JI, Nakamura MA, Godoy MV, Kuri P, Lucas CA, Conyer RT.
    J Infect Dis; 2004 May 01; 189 Suppl 1():S243-50. PubMed ID: 15106118
    [Abstract] [Full Text] [Related]

  • 19. [Rubella in São Paulo. Serological surveys in 349 subjects. Clinico-serological evaluation of 2 types of attenuated virus vaccine].
    Veronesi R, Moura RA, Penna HA, Strauss A, Zuccas WA, Issler H.
    Rev Hosp Clin Fac Med Sao Paulo; 1971 Apr 01; 26(2):65-8. PubMed ID: 5104431
    [No Abstract] [Full Text] [Related]

  • 20. Safety concerns regarding combination vaccines: the experience in Japan.
    Andreae MC, Freed GL, Katz SL.
    Vaccine; 2004 Sep 28; 22(29-30):3911-6. PubMed ID: 15364439
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.